The SOX9 upstream region prone to chromosomal aberrations causing campomelic dysplasia contains multiple cartilage enhancers

Nucleic Acids Research

Volumn 43, Issue 11, 2015, Pages 5394-5408

  Yao, Baojin ^a   Wang, Qiuqing ^a   Liu, Chia Feng ^a   Bhattaram, Pallavi ^a   Li, Wei ^a   Mead, Timothy J ^a   Crish, James F ^a   Lefebvre, Vcrossedronique ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; SOX5 PROTEIN, MOUSE; SOX6 PROTEIN, MOUSE; SOX9 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAMPOMELIC DYSPLASIA; CARTILAGE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; ENHANCER REGION; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; CARTILAGE CELL; CELL CULTURE; CELL LINEAGE; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; CYTOLOGY; GENETICS; HEK293 CELL LINE; METABOLISM; TRANSCRIPTION INITIATION;

ANIMALS; CAMPOMELIC DYSPLASIA; CELL LINEAGE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHONDROCYTES; CHROMOSOME ABERRATIONS; COS CELLS; ENHANCER ELEMENTS, GENETIC; HEK293 CELLS; HUMANS; MICE; MICE, TRANSGENIC; SOX9 TRANSCRIPTION FACTOR; SOXD TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84936797793     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv426     Document Type: Article

References (48)

1. Foster, J.W., Dominguez-Steglich, M.A., Guioli, S., Kwok, C., Weller, P.A., Stevanovic, M., Weissenbach, J., Mansour, S., Young, I.D., Goodfellow, P.N. et al. (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature, 372, 525-530.
2. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F.D., Keutel, J., Hustert, E. et al. (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell, 79, 1111-1120.
3. Unger, S., Scherer, G. and Superti-Furga, A. (2013) Campomelic dysplasia. GeneReviews. University of Washington, Seattle.
4. Akiyama, H., Chaboissier, M. C., Behringer, R. R., Rowitch, D. H., Schedl, A., Epstein, J. A. and de Crombrugghe, B. (2004) Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc. Natl. Acad. Sci. U.S.A., 101, 6502-6507.
5. Stolt, C.C. andWegner, M. (2010) SoxE function in vertebrate nervous system development. Int. J. Biochem. Cell Biol., 42, 437-440.
6. Akiyama, H. and Lefebvre, V. (2011) Unraveling the transcriptional regulatory machinery in chondrogenesis. J. Bone. Miner. Metab., 29, 390-395.
7. Reginensi, A., Clarkson, M., Neirijnck, Y., Lu, B., Ohyama, T., Groves, A.K., Sock, E., Wegner, M., Costantini, F., Chaboissier, M.C. et al. (2011) SOX9 controls epithelial branching by activating RET effector genes during kidney development. Hum. Mol. Genet., 20, 1143-1153.
8. Kawaguchi, Y. (2013) Sox9 and programming of liver and pancreatic progenitors. J. Clin. Invest., 123, 1881-1886.
9. Svingen, T. and Koopman, P. (2013) Building the mammalian testis: origins, differentiation, and assembly of the component cell populations. Genes Dev., 27, 2409-2426.
10. Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. and de Crombrugghe, B. (1999) Sox9 is required for cartilage formation. Nat. Genet., 22, 85-89.
11. Akiyama, H., Chaboissier, M.C., Martin, J.F., Schedl, A. and de Crombrugghe, B. (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 16, 2813-2828.
12. Dy, P., Wang, W., Bhattaram, P., Wang, Q., Wang, L., Ballock, R.T. and Lefebvre, V. (2012) Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. Dev. Cell, 22, 597-609.
13. Henry, S.P., Liang, S., Akdemir, K.C. and de Crombrugghe, B. (2012) The postnatal role of Sox9 in cartilage. J. Bone Miner. Res., 27, 2511-2525.
14. Fukui, N., Ikeda, Y., Ohnuki, T., Tanaka, N., Hikita, A., Mitomi, H., Mori, T., Juji, T., Katsuragawa, Y., Yamamoto, S. et al. (2008) Regional differences in chondrocyte metabolism in osteoarthritis: a detailed analysis by laser capture microdissection. Arthritis Rheum., 58, 154-163.
15. Haag, J., Gebhard, P.M. and Aigner, T. (2008) SOX gene expression in human osteoarthritic cartilage. Pathobiology, 75, 195-199.
16. Zhou, Z.Q., Ota, S., Deng, C., Akiyama, H. and Hurlin, P.J. (2014) Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes. Hum. Mol. Genet., 24, 1764-1773.
17. Matheu, A., Collado, M., Wise, C., Manterola, L., Cekaite, L., Tye, A.J., Canamero, M., Bujanda, L., Schedl, A., Cheah, K.S. et al. (2012) Oncogenicity of the developmental transcription factor Sox9. Cancer Res., 72, 1301-1315.
18. Kumar, D. and Lassar, A.B. (2009) The transcriptional activity of Sox9 in chondrocytes is regulated by RhoA signaling and actin polymerization. Mol. Cell. Biol., 29, 4262-4273.
19. Mead, T.J., Wang, Q., Bhattaram, P., Dy, P., Afelik, S., Jensen, J. and Lefebvre, V. (2013) A far-upstream (-70 kb) enhancer mediates Sox9 auto-regulation in somatic tissues during development and adult regeneration. Nucleic Acids Res., 41, 4459-4469.
20. Bi, W., Huang, W., Whitworth, D.J., Deng, J.M., Zhang, Z., Behringer, R.R. and de Crombrugghe, B. (2001) Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U. S. A., 98, 6698-6703.
21. Meyer, J., Südbeck, P., Held, M., Wagner, T., Schmitz, M.L., Bricarelli, F.D., Eggermont, E., Friedrich, U., Haas, O.A., Kobelt, A. et al. (1997) Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum. Mol. Genet., 6, 91-98.
22. Velagaleti, G.V., Bien-Willner, G.A., Northup, J.K., Lockhart, L.H., Hawkins, J.C., Jalal, S.M., Withers, M., Lupski, J.R. and Stankiewicz, P. (2005) Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia. Am. J. Hum. Genet., 76, 652-662.
23. Leipoldt, M., Erdel, M., Bien-Willner, G.A., Smyk, M., Theurl, M., Yatsenko, S.A., Lupski, J.R., Lane, A.H., Shanske, A.L., Stankiewicz, P. et al. (2007) Two novel translocation breakpoints upstream of SOX9 define borders of the proximal and distal breakpoint cluster region in campomelic dysplasia. Clin. Genet., 71, 67-75.
24. Gordon, C.T., Tan, T.Y., Benko, S., Fitzpatrick, D., Lyonnet, S. and Farlie, P.G. (2009) Long-range regulation at the SOX9 locus in development and disease. J. Med. Genet., 46, 649-656.
25. Benko, S., Fantes, J.A., Amiel, J., Kleinjan, D.J., Thomas, S., Ramsay, J., Jamshidi, N., Essafi, A., Heaney, S., Gordon, C.T. et al. (2009). Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat. Genet., 41, 359-364.
26. Wunderle, V.M., Critcher, R., Hastie, N., Goodfellow, P.N. and Schedl, A. (1998). Deletion of long-range regulatory elements upstream of SOX9 causes campomelic dysplasia. Proc. Natl. Acad. Sci. U. S. A., 95, 10649-10654.
27. Bagheri-Fam, S., Barrionuevo, F., Dohrmann, U., Gunther, T., Schule, R., Kemler, R., Mallo, M., Kanzler, B. and Scherer, G. (2006). Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern. Dev. Biol., 291, 382-397.
28. Sekido, R. and Lovell-Badge, R. (2008). Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature, 453, 930-934.
29. Han, Y. and Lefebvre, V. (2008) L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol. Cell. Biol., 8, 4999-5013.
30. Lefebvre, V., Li, P. and de Crombrugghe, B. (1998) A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J., 17, 5718-5733.
31. King, K.B. and Kimura, J.H. (2003) The establishment and characterization of an immortal cell line with a stable chondrocytic phenotype. J. Cell. Biochem., 89, 992-1004.
32. Mukhopadhyay, K., Lefebvre, V., Zhou, G., Garofalo, S., Kimura, J.H. and de Crombrugghe, B. (1995) Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene. J. Biol. Chem, 270, 27711-27719.
33. Taylor, S.M. and Jones, P.A. (1979) Multiple new phenotypes induced in C3H10T1/2 and 3T3 cells treated with 5-azacytidine. Cell, 17, 771-779.
34. Graham, F.L., Smiley, J., Russell, W.C. and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J.Gen. Virol., 36, 59-74.
35. Bhattaram, P., Penzo-Méndez, A., Kato, K., Bandyopadhyay, K., Gadi, A., Taketo, M.M. and Lefebvre, V. (2014) SOXC proteins amplify canonical WNT signaling to secure nonchondrocytic fates in skeletogenesis. J. Cell Biol., 207, 657-671.
36. Yamashiro, T., Wang, X.P., Li, Z., Oya, S., Aberg, T., Fukunaga, T., Kamioka, H., Speck, N.A., Takano-Yamamoto, T. and Thesleff, I. (2004) Possible roles of Runx1 and Sox9 in incipient intramembranous ossification. J. Bone Miner. Res., 19, 1671-1677.
37. Forni, P.E. and Wray, S. (2012) Neural crest and olfactory system: new prospective. Mol. Neurobiol., 46, 349-360.
38. Smits, P., Li, P., Mandel, J., Zhang, Z., Deng, J.M., Behringer, R.R., de Crombrugghe, B. and Lefebvre, V. (2001) The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell, 1, 277-290.
39. Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I. and Young, R.A. (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell, 153, 307-319.
40. Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-André, V., Sigova, A.A., Hoke, H.A. and Young, R.A. (2013) Super-enhancers in the control of cell identity and disease. Cell, 155, 934-947.
41. Karlsson, C. and Lindahl, A. (2009) Notch signaling in chondrogenesis. Int. Rev. Cell Mol. Biol., 275, 65-88.
42. Wang, W., Rigueur, D. and Lyons, K.M. (2014) TGF-beta signaling in cartilage development and maintenance. Birth Defects Res., Part C, 102, 37-51.
43. Kozhemyakina, E., Lassar, A.B. and Zelzer, E. (2015) A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development, 142, 817-831.
44. Lim, J., Tu, X., Choi, K., Akiyama, H., Mishina, Y. and Long, F. (2015) BMP-Smad4 signaling is required for precartilaginous mesenchymal condensation independent of Sox9 in the mouse. Dev. Biol., 400, 132-138.
45. Lefebvre, V. (2010) The SoxD transcription factors-Sox5, Sox6, and Sox13-are key cell fate modulators. Int. J. Biochem. Cell. Biol., 42, 429-432.
46. Reiprich, S. and Wegner, M. (2015) From CNS stem cells to neurons and glia: Sox for everyone. Cell Tissue Res., 359, 111-124.
47. Akiyama, H., Kim, J.E., Nakashima, K., Balmes, G., Iwai, N., Deng, J.M., Zhang, Z., Martin, J.F., Behringer, R.R., Nakamura, T. et al. (2005) Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl. Acad. Sci. U.S.A., 102, 14665-14670.
48. Pfeifer, D., Kist, R., Dewar, K., Devon, K., Lander, E.S., Birren, B., Korniszewski, L., Back, E. and Scherer, G. (1999) Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am. J. Hum. Genet., 65, 111-124.